Last reviewed · How we verify
Anti-TNFα continued perioperatively
At a glance
| Generic name | Anti-TNFα continued perioperatively |
|---|---|
| Also known as | Infliximab, Remicade, Etanercept, Enbrel, Adalimumab |
| Sponsor | CHU de Quebec-Universite Laval |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |